An SMS Intervention to Improve Adherence to Stimulant Medications in Adults With ADHD

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04189536

Enrollment

125

Registered

2019-12-06

Start date

2016-09-19

Completion date

2022-09-30

Last updated

2022-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Attention Deficit/Hyperactivity Disorder

Keywords

Attention Deficit/Hyperactivity Disorder, ADHD, SMS Intervention

Brief summary

This study will assess the efficacy of the text messaging (SMS-based) disease management intervention to improve adherence to stimulants in adults with Attention Deficit/Hyperactivity Disorder (ADHD). Participants in the study will receive customized text messages twice a day, every day, for a duration of 9 months. The text messages will include reminders to adhere to the individualized medication regimen, reminders to call their clinician for a prescription refill followed by reminders to pick up medication from the pharmacy, and educational reminders about ADHD and its treatment.

Interventions

OTHERSMS Intervention

Delivery of text messages will use the Rip Road Mobile platform.

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

OTHER

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 55 Years

Healthy volunteers

Inclusion criteria

* Male and female adults 18 to 55 years * A diagnosis of Diagnostic and Statistical Manual Diploma in Social Medicine (DSM-V) Attention Deficit Hyperactivity Disorder based on clinical assessment * Is starting stimulant medication or has begun treatment with stimulant medication within six months of study enrollment * Proficient in English * Has a cellular phone with text messaging capabilities and is interested in and willing to receive text messages

Exclusion criteria

* Serious chronic medical or psychiatric condition that, in the investigator's opinion, puts the subject at risk for taking a stimulant * Pregnant or nursing females * Investigator and his/her immediate family * Unwilling/unable to comply with study procedures

Design outcomes

Primary

Measure	Time frame	Description
Adherence to Stimulants	9 months	Adherence will be analyzed using the timeliness of stimulant medication prescription renewals over the 9 month period.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026